235 related articles for article (PubMed ID: 2508545)
1. Efficacy of mupirocin in methicillin-resistant Staphylococcus aureus burn wound infection.
Rode H; Hanslo D; de Wet PM; Millar AJ; Cywes S
Antimicrob Agents Chemother; 1989 Aug; 33(8):1358-61. PubMed ID: 2508545
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal efficacy of mupirocin in multi-antibiotic resistant Staphylococcus aureus burn wound infection.
Rode H; de Wet PM; Millar AJ; Cywes S
J Antimicrob Chemother; 1988 May; 21(5):589-95. PubMed ID: 3134320
[TBL] [Abstract][Full Text] [Related]
3. Topical Bactroban (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant staphylococci.
Strock LL; Lee MM; Rutan RL; Desai MH; Robson MC; Herndon DN; Heggers JP
J Burn Care Rehabil; 1990; 11(5):454-9. PubMed ID: 2123203
[TBL] [Abstract][Full Text] [Related]
4. [The effects of mupirocin on burned wound with Staphylococcus aureus infection].
Deng S; Sang J; Cao L
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1995 Jan; 11(1):45-8. PubMed ID: 7600433
[TBL] [Abstract][Full Text] [Related]
5. [Mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from wound infections].
Dolapçi I; Karahan ZC; Tekeli A; Koyuncu E; Azap A; Adaleti R
Mikrobiyol Bul; 2007 Jul; 41(3):435-40. PubMed ID: 17933255
[TBL] [Abstract][Full Text] [Related]
6. Novel recombinant endolysin ointment with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from wounds and burns.
Hamed ZO; Awni AA; Abdulamir AS
Arch Microbiol; 2023 Mar; 205(4):104. PubMed ID: 36869962
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of antibacterial activity of topical antimicrobials against methicillin-resistant Staphylococcus aureus].
Cui S; Han L; Xiao S; Chen X; Chang Q; Liu Y; Zhang X
Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):21-4. PubMed ID: 24684985
[TBL] [Abstract][Full Text] [Related]
8. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment.
Kauffman CA; Terpenning MS; He X; Zarins LT; Ramsey MA; Jorgensen KA; Sottile WS; Bradley SF
Am J Med; 1993 Apr; 94(4):371-8. PubMed ID: 8475930
[TBL] [Abstract][Full Text] [Related]
9. Successful control of a methicillin-resistant Staphylococcus aureus outbreak in a burn intensive care unit by addition of universal decolonization with intranasal mupirocin to basic infection prevention measures.
Kim JJ; Blevins MW; Brooks DJ; Stehle JR; McLouth CJ; Viviano JP; Holmes Iv JH; Bischoff WE
Am J Infect Control; 2019 Jun; 47(6):661-665. PubMed ID: 30616934
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of methicillin resistant Staphylococcus aureus (MRSA) isolates with high-level mupirocin resistance from patients and personnel in a burn center.
Abbasi-Montazeri E; Khosravi AD; Feizabadi MM; Goodarzi H; Khoramrooz SS; Mirzaii M; Kalantar E; Darban-Sarokhalil D
Burns; 2013 Jun; 39(4):650-4. PubMed ID: 23499497
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial, Anti-inflammatory, and Wound Healing Properties of
Jafari Z; Bardania H; Barmak MJ; Eslami S; Mahmoudi-Mourderaz Y; Roustaei N; Talebianpoor MS; Kokhdan EP; Khoramrooz SS
Biomed Res Int; 2024; 2024():6758817. PubMed ID: 38899039
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology of methicillin-resistant Staphylococcus aureus in a burn center.
Heggers JP; Phillips LG; Boertman JA; Carethers J; Weingarten M; Lentz CW; Hayden J; Robson MC
J Burn Care Rehabil; 1988; 9(6):610-2. PubMed ID: 3220868
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin.
Cederna JE; Terpenning MS; Ensberg M; Bradley SF; Kauffman CA
Infect Control Hosp Epidemiol; 1990 Jan; 11(1):13-6. PubMed ID: 2105352
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of topical mupirocin against an experimental Staphylococcus aureus surgical wound infection.
Boon RJ; Beale AS; Sutherland R
J Antimicrob Chemother; 1985 Oct; 16(4):519-26. PubMed ID: 3934130
[TBL] [Abstract][Full Text] [Related]
15. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?
Walker ES; Vasquez JE; Dula R; Bullock H; Sarubbi FA
Infect Control Hosp Epidemiol; 2003 May; 24(5):342-6. PubMed ID: 12785407
[TBL] [Abstract][Full Text] [Related]
16. Control of methicillin-resistant Staphylococcus aureus in a pediatric burn unit.
Sheridan RL; Weber J; Benjamin J; Pasternack MS; Tompkins RG
Am J Infect Control; 1994 Dec; 22(6):340-5. PubMed ID: 7695112
[TBL] [Abstract][Full Text] [Related]
17. Comparison of silver sulfadiazine 1%, mupirocin 2%, and fusidic acid 2% for topical antibacterial effect in methicillin-resistant staphylococci-infected, full-skin thickness rat burn wounds.
Acikel C; Oncul O; Ulkur E; Bayram I; Celikoz B; Cavuslu S
J Burn Care Rehabil; 2003; 24(1):37-41. PubMed ID: 12543989
[TBL] [Abstract][Full Text] [Related]
18. The novel antibacterial drug XF-70 is a potent inhibitor of Staphylococcus aureus infection of the burn wound.
Hurtuk MG; He LK; Szilagyi A; Gamelli RL; Hecht DW; Kennedy RH; Rhys-Williams W; Love WG; Shankar R
J Burn Care Res; 2010; 31(3):462-9. PubMed ID: 20453736
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of topical 2% mupirocin ointment for treatment of tympanostomy tube otorrhea caused by community-acquired methicillin resistant Staphylococcus aureus.
Yankey H; Isaacson G
Int J Pediatr Otorhinolaryngol; 2018 Jun; 109():36-39. PubMed ID: 29728181
[TBL] [Abstract][Full Text] [Related]
20. Adaptation of methicillin-resistant Staphylococcus aureus during antibiotic therapy.
Menzies RE; Cornere BM; MacCulloch D
J Antimicrob Chemother; 1989 Jun; 23(6):923-7. PubMed ID: 2503489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
